Corvus Pharmaceuticals, Inc. (CRVS) free cash flow

Free cash flow · fiscal 2025
-$32.97M

Corvus Pharmaceuticals, Inc. (CRVS) generated free cash flow of -$32.97M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$25.42M. Figures as of 18 Nov 2026, 12:43 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
-$32.97M
Highest on record
-$13.08Mfiscal 2015
Lowest on record
-$46.48Mfiscal 2017
Fiscal years on record
112015–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Corvus Pharmaceuticals, Inc. free cash flow, in more detail

Across the 11 fiscal years on record (2015–2025), the highest was -$13.08M in fiscal 2015 and the lowest -$46.48M in fiscal 2017.

History · 11 fiscal years

Free cash flow by fiscal year

Corvus Pharmaceuticals, Inc. free cash flow, year by year

Corvus Pharmaceuticals, Inc. (CRVS) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025-$32.97M—
2024-$25.42M—
2023-$23.97M—
2022-$27.29M—
2021-$36.72M—
2020-$34.85M—
2019-$37.35M—
2018-$41.34M—
2017-$46.48M—
2016-$30.06M—
2015-$13.08M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

More on CRVS

Corvus Pharmaceuticals, Inc., figure by figure

Corvus Pharmaceuticals, Inc. (CRVS) overview: price, valuation and scorecard

Corvus Pharmaceuticals, Inc. free cash flow: questions and answers

What is Corvus Pharmaceuticals, Inc.'s free cash flow?

Corvus Pharmaceuticals, Inc. (CRVS) generated free cash flow of -$32.97M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$25.42M.

What are the highest and lowest free cash flow figures on record for Corvus Pharmaceuticals, Inc.?

Across the 11 fiscal years on record (2015–2025), the highest was -$13.08M in fiscal 2015 and the lowest -$46.48M in fiscal 2017.

How is Corvus Pharmaceuticals, Inc.'s free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Corvus Pharmaceuticals, Inc. it is on record here for 11 fiscal years, 2015 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Corvus Pharmaceuticals, Inc. (CRVS) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/CRVS/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.